Results 231 to 240 of about 88,754 (292)

A phase 2 study of adjuvant chemotherapy with 5‐fluorouracil/leucovorin and oxaliplatin after lung metastasectomy for colorectal cancer (WJOG5810G)

open access: yesCancer, Volume 131, Issue 7, 1 April 2025.
Abstract Background The clinical significance of adjuvant chemotherapy after lung metastasectomy for colorectal cancer remains unknown. This phase 2 study evaluated adjuvant chemotherapy with modified 5‐fluorouracil/leucovorin and oxaliplatin (mFOLFOX6) after lung metastasectomy.
Nozomu Machida   +18 more
wiley   +1 more source

Immune checkpoint inhibitor restores daily function in patient with microsatellite instability (MSI)-high advanced endometrial cancer and poor performance status. [PDF]

open access: yesInt Cancer Conf J
Matsui A   +11 more
europepmc   +1 more source

Predicting Prognosis and Immunotherapy Response in Glioblastoma (GBM) With a 5‐Gene CAF‐Risk Signature

open access: yesCancer Reports, Volume 8, Issue 4, April 2025.
ABSTRACT Background Cancer‐associated fibroblasts (CAF) represent significant constituents within the extracellular matrix (ECM) across a range of cancers. Nevertheless, there exists a scarcity of direct proof concerning the function of CAF in glioblastoma (GBM).
Haifeng He   +7 more
wiley   +1 more source

BRCA2‐Related Hereditary Cancer Syndrome‐Associated Small Bowel Adenocarcinoma With Multiple BRCA2 Mutations: A Case Report and Review of the Literature

open access: yesCancer Reports, Volume 8, Issue 4, April 2025.
ABSTRACT Background Small bowel adenocarcinomas (SBAs) are rare and aggressive cancers. About one‐fifth of SBA patients have predisposing conditions; among them, there are also genetic tumor syndromes, including Lynch syndrome, familial adenomatous polyposis, and Peutz‐Jeghers syndrome.
Francesca Antoci   +12 more
wiley   +1 more source

A myeloid IFN gamma response gene signature correlates with cancer prognosis

open access: yesClinical and Translational Medicine, Volume 15, Issue 4, April 2025.
IFGRNS score is a novel prognostic biomarker upregulated in myeloid lineage cells. IFGRNS score correlates with survival outcomes across multiple cancer types. IFGRNS score is associated with tumour pathology and immune microenvironment. IFGRNS score predicts immunotherapy response, with potential for clinical application. Abstract Background The IFN‐γ
Yuchao Zhang   +8 more
wiley   +1 more source

Dynamics of blood microsatellite instability (bMSI) burden predicts outcome of a patient treated with immune checkpoint inhibitors: a case report of hyperprogressive disease. [PDF]

open access: yesFront Immunol
Kravchuk D   +13 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy